Protalix (PLX) Gets Orphan Drug Recommendation on Taliglucerase Alfa
Protalix (NYSE: PLX) gets recommendation for orphan drug on taliglucerase alfa
Create E-mail AlertRelated Categories
Corporate NewsFDA
Hot List
Stocks Mentioned
-0.10Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
